ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2022 Congress

July 9-13, 2022. London, England, UK.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z
  • Abstract Number: PB0343

    N-Acetyl Cysteine Prevents Occlusive Arterial Thrombosis in a Dose-Dependent Manner

    C. Bresette1, K. Ashworth2, J. Di Paola3, D. Ku4

  • Abstract Number: OC 04.3

    N-glycan-mediated shielding of ADAMTS13 effectively prevents binding of pathogenic autoantibodies in high-titer patients with immune-mediated Thrombotic Thrombocytopenic Purpura

    T. Postmus1, N. Graca2, B. Ercig2, B. Luken3, P. Coppo4, A. Veyradier5, K. Vanhoorelbeke6, J. Voorberg7

  • Abstract Number: OC 77.2

    Na+/K+ ATPase alpha 1 subunit participates in platelet signaling and is a potential anti-thrombotic target

    O. Li1, R. Aguilar2, R. Roytenberg1, H. Yue3, E. Thompson2, S. Pierre4, J. Liu1, W. Li3

  • Abstract Number: OC 61.5

    National Incidence of Bleeding-Related Hospitalisations and Mortality by Anatomical and ISTH site classification in England 2014-2019

    K. Creeper1, A. Stafford2, S. Choudhuri3, N. Tumian4, K. Breen5, A. Cohen6

  • Abstract Number: PB0981

    Nationwide analysis of Pre-Hospital Tranexamic Acid in trauma patients at risk of bleeding

    A. Almuwallad1, A. Rossetto2, E. Cole2, R. Davenport3

  • Abstract Number: PB0053

    NET formation in patients with COVID-19 and non-COVID-19 ARDS on venovenous ECMO

    N. Buchtele1, M. Kollars2, H. Burgmann3, P. Kyrle2, T. Staudinger4, S. Eichinger5, L. Traby6

  • Abstract Number: PB0745

    NETosis in Sickle Cell Anemia

    A. TOMBAK1, G. Hatem2, L. Tamer2, N. Tiftik2, N. Yilmaz2

  • Abstract Number: PB1400

    Neurologically asymptomatic patients with pure obstetric antiphospholipid syndrome cumulate progressive microstructural brain damages, mild functional abnormalities, and subtle cognitive impairments

    J. GRIS1, S. Sandiramourty2, T. Hai Nguyen2, J. Beregi2, F. Pereira3

  • Abstract Number: PB0008

    Neutralizing anti-emicizumab antibodies in a patient with Acquired Hemophilia A

    B. Pezeshkpoor1, N. Sereda1, A. Berkemeier1, J. Müller2, S. Singh1, S. Ramaraje Urs2, C. Klein1, S. Horneff1, G. Goldmann1, N. Marquardt1, J. Oldenburg3

  • Abstract Number: PB0221

    Neutralizing antidrug antibody to emicizumab: Detailed laboratory evaluation and review of the literature

    H. KIZILOCAK1, J. Brown2, G. Young3

  • Abstract Number: PB0731

    Neutrophil activation markers as novel biomarkers for advanced stages of high-grade serous ovarian cancer

    J. Oto1, B. Mc Cormack2, S. Tomás-Pérez2, A. Fernández-Pardo3, E. González-Cantó2, F. Cana3, C. Aghababyan4, R. Herranz1, S. Cañete-Mota5, A. Cuadros-Lozano4, L. Martínez-Fernández4, A. Aranda-Borreda2, A. Arroyo-Álvarez2, N. Santonja-López6, R. Ramírez-Belloch7, A. Llueca-Abella8, J. Marí-Alexandre J2, J. Gilabert-Estellés9, P. Medina3

  • Abstract Number: OC 46.2

    Neutrophil Cathepsin G Cleaves Fibrinogen Affecting Clot Structure

    S. Smith, J. Morrissey

  • Abstract Number: OC 68.5

    Neutrophil Extracellular Traps as a Mediator of Cerebral Ischemia and Reperfusion Injury in Ischemic Stroke

    M. De Wilde1, S. Staessens1, L. Desender1, C. Tersteeg2, K. Vanhoorelbeke2, S. De Meyer2

  • Abstract Number: OC 20.1

    Neutrophil Extracellular Traps promote joint injury in hemophilia

    T. Kaminski, T. Brzoska, E. Tutuncouglu, M. Ragni, P. Sundd

  • Abstract Number: OC 38.2

    Neutrophils and platelets collaborate to induce an increase NET formation during JAK2V617F positive myeloproliferative neoplasms

    A. Guy1, V. Gourdou-Latyszenok2, L. Wolff-Thrombini2, S. Favre2, S. Labrouche-Colomer3, M. Renault2, C. James2

  • Abstract Number: OC 72.2

    Neutrophils protect against Staphylococcus aureus endocarditis but the impact of NET release is negated by coagulases

    S. Meyers1, M. Lox2, S. Kraisin2, C. Martens3, L. Liesenborghs2, L. Frederix2, D. Missiakas4, P. Baatsen5, T. Vanassche6, P. Verhamme2, K. Martinod3

  • Abstract Number: PB0371

    New experimental evidence for a role of platelets in cholesterol-induced vascular and valvular calcification

    Z. Jiang1, C. Oury2

  • Abstract Number: VPB1168

    New Technologies such as Virtual Reality to increase Adherence in Hemophilia Treatment

    A. santamaria1, T. Lobez2, M. Sanchez3, S. García Barcenilla4, J. Farriol5, L. Pérez6, D. García6

  • Abstract Number: PB1059

    Next-generation FVIII mimetic, Mim8, does not interfere with non-factor VIII haemostasis assays.

    A. Bowyer1, K. Hickey2, S. Kitchen3, M. Ezban4

  • Abstract Number: VPB0109

    NLRP3 inflammasome activation and immunothrombosis in COVID-19.

    A. Cambon1, C. Guervilly2, C. Delteil3, R. Bachelier4, N. Potere5, E. Abdili6, J. Forel7, F. Dignat-George8, S. Hraiech2, R. Lacroix9, L. Papazian10, G. Kaplanski11

  • Abstract Number: VPB0696

    No difference in the management of Covid-19 hemophilic and non-hemophilic patients

    G. Sottilotta1, G. Nicolò2, C. Mangano3, F. Luise4, A. Piromalli4

  • Abstract Number: PB0441

    No pharmacological effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in patients with breast cancer: the PHIX-IT study

    F. Bosch1, F. Mulder2, A. Willemsen3, M. Rentinck3, N. van Es4, R. Mathôt5, P. Kamphuisen6

  • Abstract Number: OC 45.3

    Non-invasive In Vivo Thrombus Imaging in Patients with Ischaemic Stroke or Transient Ischaemic Attack.

    B. Whittington1, D. Newby1, E. Tzolos1, M. Williams1, J. Wardlaw2, E. Van Beek3, R. Bing1, T. Clark1, C. Lucatelli1, W. Whiteley1, P. Slomka4, M. Dweck1, A. Stephens5, N. Koglin5

  • Abstract Number: VPB1350

    Non-O Blood Type is Risk Factor for Venous Thromboembolism in Acutely Injured Patients Requiring Orthopaedic Surgery

    P. Schneider, S. Yee, J. Petrowitsch, A. Clarke, L. Yamaura, K. Rondeau, L. Skeith

  • Abstract Number: PB1281

    Non-parenchymal origin of alternatively spliced tissue factor in chronic liver disease

    C. Lewis1, K. Stone1, D. Kuhnell2, S. Langevin2, A. Soto-Gutierrez3, P. Van Dreden4, J. Luyendyk5, V. Bogdanov6

  • Abstract Number: PB1175

    Norwegian Real-World Experience with recombinant factor IX Fc (rFIXFc) in Haemophilia B (HB) Patients

    P. Holme1, H. Glosli2, J. Thanner3, K. Sennfält3

  • Abstract Number: PB1176

    Norwegian Real-World Experience with recombinant factor VIII Fc (rFVIIIFc) in Haemophilia A (HA) Patients

    P. Holme1, H. Glosli2, J. Thanner3, K. Sennfält3

  • Abstract Number: PB1127

    Novel accreditation of European haemophilia treatment and gene therapy centres

    A. Boban1, F. Baghaei Borzabadi2, K. Fijnvandraat3, R. Klamroth4, W. Miesbach5, D. Stephensen6, M. Kavanagh7, D. Noone8, M. Crato9, F. Peyvandi10

  • Abstract Number: OC 26.3

    Novel Flow Cytometric Diagnostic Assay for Primary Immune Thrombocytopenia.

    P. Woolley1, A. Constantinescu-Bercu2, M. Stubbs3, R. de Groot2, J. Westwood3, Y. Guo4, M. Scully5

  • Abstract Number: OC 64.3

    Novel GNE gene variants associated with severe congenital thrombocytopenia and platelet sialylation defect – follow up data after hematopoietic stem cell transplantation

    B. Zieger1, D. Boeckelmann2, W. Anani3, H. Falet4, J. Zhu3, H. Glonnegger1, H. Full5, F. Andresen1, M. Erlacher1, E. Lausch6, S. Fels1, B. Strahm1, P. Lang7, K. Hoffmeister8

  • Abstract Number: PB1185

    Novel miniaturized Chemiluminescent-based Factor VIII activity assay

    D. Steeghs, M. van Geffen, W. van Heerde, C. van 't Veer

  • Abstract Number: PB1234

    Novel Pathological GATA1 Variant Leads to Defective Platelet Biogenesis via Impaired Transcriptional Regulation

    K. Butov1, Z. Kondrashova2, S. Obydennyi1, A. Ignatova3, N. Podoplelova1, M. Kurnikova1, E. Raykina3, E. Osipova1, G. Novichkova1, E. Donyush2, K. Machlus4, M. Panteleev5

  • Abstract Number: OC 59.4

    Novel variants in GALE caused syndromic macrothrombocytopenia disrupting thrombopoiesis and glycosylation

    A. Marin-Quilez1, C. Di Buduo2, L. Díaz-Ajenjo1, P. Soprano3, E. Vuelta1, I. Serramito-Gómez1, S. Santos-Mínguez1, C. Miguel-García1, S. Tocino-Antonio4, A. Zamora-Canovas5, P. Ruiz-Sala6, M. Peñarrubia7, E. Pardal8, J. Hernández-Rivas9, J. González-Porras10, R. Benito1, J. Rivera11, I. García-Tuñón1, A. Balduini12, J. Bastida13

Jump to:  View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley